drugset / Trial / NCT01429545

Single Versus Combination Therapy in Acute Tocolysis

NCT01429545

Phase 2 Completed 110 enrolled Tawam Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to compare the tocolytic efficacy, effectiveness and safety of Atosiban in comparison with the combination of Atosiban and Nifedipine together.

Timeline

Start
2007-04
Primary completion
2010-09
Completion
2011-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Atosiban Other / unclassified 6 mg Intravenous
Subject Nifedipine Other / unclassified 10 mg Oral

Indications

No indication recorded.